28 reports

2016 Emerging Opportunities in the Japanese HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) JAPANESE AIDS TESTING MARKET Major Companies Developing or Marketi

  • Diagnostics
  • Immunochemistry Test
  • Japan
  • Company Sales
  • Demand

2016 Emerging Opportunities in the Italian HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs, -- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) ITALIAN AIDS TESTING MARKET Major Companies Developing or Marketin

  • Diagnostics
  • Immunochemistry Test
  • Italy
  • Company Sales
  • Demand

2016 Emerging Opportunities in the German HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs, -- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) GERMAN AIDS TESTING MARKET Major Companies Developing or Marketing

  • Diagnostics
  • Immunochemistry Test
  • Germany
  • Company Sales
  • Demand

2016 Emerging Opportunities in the French HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) FRENCH AIDS TESTING MARKET Major Companies Developing or Marketing

  • Diagnostics
  • Immunochemistry Test
  • France
  • Company Sales
  • Demand

2016 Emerging Opportunities in the Spanish HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) SPANISH AIDS TESTING MARKET Major Companies Developing or Marketing

  • Diagnostics
  • Immunochemistry Test
  • Spain
  • Company Sales
  • Demand
  • TAIWAN: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • IMMUNOASSAY MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)

In Brazil, in 2014, around ##, ## to ## million individuals had acquired HIV/ AIDS (Source: UNAIDS) Additionally, in APAC in 2013, around five million people had acquired HIV/ AIDS, with ~##, ## newly diagnosed cases (Source: UNAIDS).

  • Immunochemistry Test
  • Market Size
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Sysmex Corporation

ALERE DETERMINE IS A MULTIPLEXED HIV TEST ABLE TO DETECT BOTH HIV ##& ##-SPECIFIC ANTIBODIES AND HIV-## P## ANTIGEN.

  • Immunochemistry Test
  • United States
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group
  • Market segmentation by application

In January 2014, the Health Resource and Services Administration HIV/ AIDS Bureau announced five new sources of funding through the Ryan White HIV/ AIDS Program.

  • Immunochemistry Test
  • In Vitro Diagnostics
  • United States
  • Beckman Coulter, Inc.
  • Roche Group
  • EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)
  • Immunochemistry Test
  • Europe
  • Alere Inc.
  • Beckman Coulter, Inc.
  • bioMerieux S.A.

An estimated ##, ## Americans were diagnosed with HIV infection and ##, ## were diagnosed with AIDS in 2013.

  • Immunochemistry Test
  • In Vitro Diagnostics
  • United States
  • Alere Inc.
  • Beckman Coulter, Inc.

In September 2014, Roche launched the Global Access Program for HIV viral load testing, created in partnership with the Joint United Nations Programme on HIV/ AIDS (UNAIDS), the Clinton Health Access Initiative (CHAI), the President' s Emergency Plan For

  • Immunochemistry Test
  • United States
  • Alere Inc.
  • Cepheid
  • Roche Group

AIDS CASES).

  • Immunochemistry Test
  • China
  • Abbott Laboratories, Inc.
  • Immucor, Inc.
  • Roche Group

AIDS cases).

  • Immunochemistry Test
  • World
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Roche Group

Its Enzygnost HIV Integral ## assay provides a qualitative determination of HIV antibodies such as HIV-##, HIV-## group O, and HIV-##, plus p## antigen.

  • Immunochemistry Test
  • World
  • DiaSorin S.p.A.
  • Roche Group
  • Thermo Fisher Scientific, Inc.

There are approximately ##, ## people living with HIV/ AIDS in China.

  • Immunochemistry Test
  • United States
  • Grifols, S.A.
  • Hologic, Inc.
  • Immucor, Inc.
  • 7.1 INTRODUCTION
  • HIV-1 SCREENING TESTS MARKET SIZE FOR HOME ACCESS DRIED BLOOD SPOTS, BY REGION, 2014-2021 (USD MILLION)
  • HIV Diagnostic
  • Immunochemistry Test
  • World
  • Market Size
  • Roche Group
  • Systems Laboratories (DSL), a provider of specialty immunoassays.

In 2007, Imperial College of London has given a grant to the company to develop quality assurance and quality control materials used to verify the accuracy of a planned point-of-care HIV/ AIDS test.

  • Immunochemistry Test
  • United States
  • Company
  • Deals & Alliance
  • Beckman Coulter, Inc.
  • 2016 VS. 2021 (USD BILLION)
  • ITALY: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)

According to UNAIDS' HIV and AIDS estimates in 2015, the number of people living with HIV in Italy was reported as ##, ##.

  • Immunochemistry Test
  • Europe
  • Forecast
  • Market Size
  • Roche Group

Biomedical and life science research activities use antibodies for drug discovery and development and for developing diagnostic tools for various diseases, like cancer, HIV-AIDS, infectious diseases, and neurological disorders.

  • Immunochemistry Test
  • World
  • Forecast
  • Market Size
  • Merck & Co., Inc.

The company' s flagship product, CD## BioChip system revolutionized the monitoring of treatment for HIV/ AIDS patients.

  • Diagnostics
  • Immunochemistry Test
  • United States
  • Company
  • GlobalData's company

THE INITIATIVE HAS HELPED NEARLY ##, ## PATIENTS BY PROVIDING THE CRITICAL RESOURCES FOR INNOVATIVE PROGRAMS OFFERING DIABETES TREATMENT AND INTERVENTIONS, HIV/ AIDS AND CERVICAL CANCER SCREENINGS AND PATIENT EDUCATION.

  • Immunochemistry Test
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • United States
  • GlobalData's company

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Clinical Trial
  • Immunochemistry Test
  • Ovarian Cancer
  • United States
  • GlobalData's company

HIV/ AIDS and other life threatening diseases.

  • Clinical Trial
  • Immunochemistry Test
  • Pancreatic Cancer
  • United States
  • GlobalData's company

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Immunochemistry Test
  • In Vitro Diagnostics
  • United States
  • Company Financials
  • GlobalData's company

THE MORTALITY RATE DUE TO SEPSIS IS MORE THAN THE COMBINED MORTALITY RATE FOR HIV/ AIDS AND BREAST & PROSTATE CANCERS.

  • Blood Culture
  • Blood Disease
  • Immunochemistry Test
  • Market Size
  • Thermo Fisher Scientific, Inc.

ITS LABORATORY TESTS INCLUDE FIBROMYALGIA, LASSA FEVER, GULF WAR SYNDROME, LUPUS, JUVENILE RA, GRAVES' DISEASE, BREAST CANCER AND NON-HIV AIDS.

  • Clinical Trial
  • Immunochemistry Test
  • In Vitro Diagnostic Reagent
  • United States
  • GlobalData's company

Immunoassays Markets

4091 4500 3477
  • EMERGING INTERNATIONAL MARKETS

GLOBAL INITIATIVES SUPPORTED BY ORGANIZATIONS SUCH AS THE CLINTON FOUNDATION HIV/ AIDS INITIATIVE, ROLL BACK MALARIA, UNAID, UNITED STATES PRESIDENT' S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR), THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA AND WOR

  • Immunochemistry Test
  • In Vitro Diagnostics
  • Infectious Disease
  • United States
  • Company

The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV/ AIDS, hepatitis, and organ transplant rejection.

  • Drug Discovery And Development
  • Immunochemistry Test
  • United States
  • Company
  • GlobalData's company